000 01684 a2200445 4500
005 20250518041345.0
264 0 _c20200929
008 202009s 0 0 eng d
022 _a1943-0264
024 7 _a10.1101/cshperspect.a035196
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDistelhorst, Clark W
245 0 0 _aCreating a New Cancer Therapeutic Agent by Targeting the Interaction between Bcl-2 and IP
_h[electronic resource]
260 _bCold Spring Harbor perspectives in biology
_c09 2019
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aBridged Bicyclo Compounds, Heterocyclic
_xpharmacology
650 0 4 _aCalcium Signaling
650 0 4 _aCell Death
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
650 0 4 _aCell Survival
650 0 4 _aEndoplasmic Reticulum
_xmetabolism
650 0 4 _aFeedback, Physiological
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aImmune System
650 0 4 _aInositol 1,4,5-Trisphosphate Receptors
_xmetabolism
650 0 4 _aMice
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProtein Domains
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xmetabolism
650 0 4 _aSignal Transduction
650 0 4 _aSulfonamides
_xpharmacology
700 1 _aBootman, Martin D
773 0 _tCold Spring Harbor perspectives in biology
_gvol. 11
_gno. 9
856 4 0 _uhttps://doi.org/10.1101/cshperspect.a035196
_zAvailable from publisher's website
999 _c29711257
_d29711257